Your Prescription Drugs Are About to Become Less Safe if Health Canada Has Its Way

Joel Lexchin

In a little-noticed announcement in October 2017, Health Canada signalled its intention to raise the fees that drug makers will have to pay when they want to get a new medication on the market.

These user fees currently fund about 50 per cent of Health Canada’s operating budget for regulating prescription drugs. Health Canada wants to increase that to 90 per cent. In addition, it will rebate 25 per cent of that fee if it fails to review new drug applications within an established period of time.

… The introduction of user fees in Canada in 1994 was associated with a decrease in the time taken for drugs to get through the review process and onto the market. This means drugs now spend longer on the market under patent protection and produce more profits for drug companies.

… Even though it’s often argued that faster drug approval is important to get new drugs to patients more rapidly, there is no evidence of a benefit to public health and considerable evidence of harm.

… Evidence of a poorer safety profile for drugs approved faster should serve as a warning against excessive pressure on reviewers exercising due diligence.

Latest articles

Yuhong Dong In part 1 and part 2 of this series, we...
Yuhong Dong While the underlying mechanisms causing these autoimmune reactions are not...
Yuhong Dong The decline of public trust in COVID-19 vaccines significantly impacts...
Michael Passwater Vitamin D has important influences on many phases in the... When understanding the construct of an immune system we must begin...
Travis Noakes A major concern is that this agenda lacks earnest discussion...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!